The study of the treatment of Male Menopause with MSC-CM

JRCT ID: jRCT1051240020

Registered date:07/05/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: the Treatment for Male Menopause
• Date of first enrollment: 07/05/2024
• Study type: Observational

Outcome(s)

• Primary Outcome: Blood tests
• Secondary Outcome: subjective symptoms, etc.

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Male

Include criteria

"1. The person whose AMS score is 37 point or higher with total testosterone level of lower than 250 ng/dL or free testosterone level of lower than 7.5 pg/mL.
2. Regardless of the item 1. above, the person who is diagnosed as a male menopause.
3. Those for whom satisfactory improvement effects were not observed with standard therapy.
4. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and have been deemed suitable for treatment with conditioned medium by a physician.

The patient selection criteria are as follows:
<Inclusion Criteria>
Patients meeting the following criteria will be considered eligible:
1. Individuals aged 18 and above.
2. Individuals with normal decision-making capacity.
3. Individuals who have been provided with the informed consent document regarding this treatment, received sufficient explanation, and can provide voluntary written consent.
4. Individuals for whom the attending physician has recognized the necessity of treatment."

Exclude criteria

"<Exclusion Criteria>
Individuals meeting any of the following conditions will be excluded from the study:
1. Users of narcotics or stimulants.
2. Individuals deemed inappropriate by the attending physician"

Related Information

• Primary Sponsor: Hirayama Takashi